Dahms N M, Rose P A, Molkentin J D, Zhang Y, Brzycki M A
Department of Biochemistry, Medical College of Wisconsin, Milwaukee 53226.
J Biol Chem. 1993 Mar 15;268(8):5457-63.
The extracytoplasmic region of the bovine cation-independent mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGF-II receptor) consists of 15 homologous repeating domains, each of which is approximately 147 residues in length. The receptor contains two high affinity mannose 6-phosphate (Man-6-P) binding sites and our recent studies (Westlund, B., Dahms, N. M., and Kornfeld, S. (1991) J. Biol. Chem. 266, 23233-23239) have localized these two binding sites to domains 1-3 and 7-11. To further define the location of the Man-6-P binding sites and to determine the role of specific arginine residues in Man-6-P binding, site-directed mutagenesis was utilized to create truncated soluble forms of the M6P/IGF-II receptor in conjunction with either conservative (Lys) or nonconservative (Ala) replacement of arginine residues. These mutants were expressed transiently in COS-1 cells and assayed for their ability to bind phosphomannosyl residues by affinity chromatography. Analysis of the ligand binding activity of carboxyl-terminal truncated forms of the receptor's extracytoplasmic region demonstrated that the second Man-6-P binding site is contained within domains 7-9. Substitution of Arg435 in domain 3 of the amino-terminal binding site and Arg1334 in domain 9 of the second binding site results in a dramatic loss of ligand binding activity. However, substitutions at positions 435 and/or 1334 did not affect the secretion, glycosylation, or immunoreactivity of these truncated proteins. Taken together, these results indicate that Arg435 and Arg1334 are essential components of the M6P/IGF-II receptor's high affinity Man-6-P binding sites.
牛阳离子非依赖性甘露糖6-磷酸/胰岛素样生长因子II受体(M6P/IGF-II受体)的胞外区域由15个同源重复结构域组成,每个结构域长度约为147个残基。该受体含有两个高亲和力甘露糖6-磷酸(Man-6-P)结合位点,我们最近的研究(韦斯特隆德,B.,达姆斯,N.M.,和科恩菲尔德,S.(1991年)《生物化学杂志》266卷,23233 - 23239页)已将这两个结合位点定位到结构域1 - 3和7 - 11。为了进一步确定Man-6-P结合位点的位置,并确定特定精氨酸残基在Man-6-P结合中的作用,采用定点诱变技术构建了M6P/IGF-II受体的截短可溶性形式,并对精氨酸残基进行保守(赖氨酸)或非保守(丙氨酸)替换。这些突变体在COS-1细胞中瞬时表达,并通过亲和色谱法检测它们结合磷酸甘露糖基残基的能力。对受体胞外区域羧基末端截短形式的配体结合活性分析表明,第二个Man-6-P结合位点位于结构域7 - 9内。氨基末端结合位点结构域3中的精氨酸435和第二个结合位点结构域9中的精氨酸1334被替换后,配体结合活性显著丧失。然而,435位和/或1334位的替换并不影响这些截短蛋白的分泌、糖基化或免疫反应性。综上所述,这些结果表明精氨酸435和精氨酸1334是M6P/IGF-II受体高亲和力Man-6-P结合位点的重要组成部分。